重大活動
FMA 2024 Medical Exhibition
The FMA 2024 event brought together professionals and leading scholars from various fields to share the latest medical research and practical experiences.
GBC showcased its Chemiluminescence Immunoassay (CLIA) technology, which is widely applied in tumor markers, thyroid function, infectious diseases, hormones, cytokines, cardiovascular, and other diagnostic areas. With high efficiency and precision (120-200 tests per hour), it meets the clinical laboratories’ demand for efficient solutions.
Additionally, the GBC AIO M160 Fully Automated Nucleic Acid Detection System is an integrated molecular diagnostics platform that combines DNA/RNA extraction, amplification, and data analysis functions. It features rapid and accurate detection (16 samples in 1-2 hours), safety (preventing cross-contamination), and convenience (fully automated workflow), effectively addressing modern diagnostic needs.
The exhibition was a resounding success! We look forward to collaborating with more professionals in future medical society events to drive advancements in the medical field.
Stay tuned to our official platforms for the latest updates!
